cbdMD, Inc. (YCBD)

NYSEAMERICAN: YCBD · USD

$0.42

+0.02 (+5.6%)· Recorded snapshot

Market cap	4.7M
Revenue (ttm)	20.9M
Net income (ttm)	-3.1M
EPS (ttm)	-$0.32
Shares out	11.2M
Volume	273,835.311
Beta	2.37

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 20.9M
Net income (ttm): -3.1M
EPS (ttm): -$0.32
Market cap: 4.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-40.3

P25 n/aP50 n/aP75 n/a

ROIC-20.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All YCBD indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001644903
Company name	cbdMD, Inc.
Country	United States
Country code	US
CUSIP number	12482W408
Earnings date	2026-12-18
Earnings time	amc
Employees	42
Employees change	-10
Employees growth	-19.23%
Enterprise value	$4.8M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	September
Founded	2015
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US12482W4087
Last 10-K release date	2025-12-19
Last earnings date	2026-08-13
Last refreshed	2026-11-04
Last stock split date	2025-05-07
Last stock split type	Reverse
Market cap	$4.7M
Market cap category	Nano-Cap
Next earnings date	2026-12-18
Options	No
Price	$0.42
Price currency	USD
Sector	Healthcare
SIC code	2844
Stock price date	2026-11-03
Symbol	YCBD
U.S. state	North Carolina
Website	https://www.cbdmd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-75.36%
EV/Sales	0.23x
FCF / EV yield	-50.31%
FCF yield	-51.32%
Forward EV/Sales	0.18x
Forward P/S	0.18x
Industry forward P/E	13.77x
Industry P/E	94.3x
P/B ratio	0.57x
P/S ratio	0.22x
Price / tangible book value	0.78x
Sector forward P/E	24x
Sector P/E	49.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-13.87%
EBITDA margin	-9.01%
Gross margin	57.68%
Operating margin	-13.87%
Pretax margin	-13.8%
Profit margin	-13.8%
Profit per employee	$-73,324
Revenue per employee	$498,368
ROA	-15.75%
ROA (5Y)	-14.43%
ROCE	-28.84%
ROE	-40.33%
ROE (5Y)	-70.99%
ROIC	-20.74%
SBC / revenue	1.8%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	3
Gross profit growth	3.68%
Gross profit growth (Q)	7.29%
Gross profit growth 3Y	-9.7%
Gross profit growth 5Y	-16.98%
Net income growth quarters	4
Net income growth years	3
Revenue growth	10.02%
Revenue growth (Q)	20.56%
Revenue growth (QoQ)	-1.53%
Revenue growth 3Y	-7.33%
Revenue growth 5Y	-14.71%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-191,419
Depreciation and amortization	$1M
EBIT	$-2.9M
EBITDA	$-1.9M
EPS	$-0.32
FCF per share	$-0.22
Financing cash flow	$3.4M
Free cash flow	$-2.4M
Free cash flow minus SBC	$-2.8M
Gross profit	$12.1M
Investing cash flow	$-134,992
Net borrowing	$61,990
Net cash flow	$1.1M
Net income	$-3.1M
Operating cash flow minus SBC	$-2.6M
Operating income	$-2.9M
Revenue	$20.9M
Stock-based compensation	$376,944

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-17.07
Book value per share	$0.74
Debt / EBITDA	28.33
Debt / equity	0.27
Goodwill	$190,000
Long-term assets	$5.4M
Long-term liabilities	$1.9M
Net cash (debt)	$-93,925
Net cash / market cap	-2%
Net debt / equity	0.01
Piotroski F-Score	3
Property, plant and equipment	$2.5M
Shareholders' equity	$8.2M
Tangible book value	$6M
Tangible book value per share	$0.54
Total assets	$13.1M
Total cash	$2.1M
Total debt	$2.2M
Total liabilities	$4.9M
WACC	11.76%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.82
Current assets	$7.7M
Current liabilities	$3.1M
Current ratio	2.5
Inventory turnover	2.67
Net working capital	$2.9M
Quick ratio	1.26
Working capital	$4.6M
Working capital turnover	6.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-382.43%
Dividend yield	0%
Shareholder yield	-382.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.61
1D price change	5.62%
1M price change	-8.11%
1M total return	-8.11%
1W price change	13.24%
1W total return	13.24%
1Y price change	-52.09%
1Y return CAGR	-52.11%
1Y total return	-52.09%
20-day SMA	$0.38
200-day SMA	$0.66
3M price change	-17.34%
3M total return	-17.34%
3Y price change	-92.28%
3Y return CAGR	-57.42%
3Y total return	-92.28%
50-day SMA	$0.44
50-day SMA vs 200-day SMA	50under200
52-week high	$2.56
52-week high date	2025-12-18
52-week low	$0.33
52-week low date	2026-10-13
5Y price change	-99.93%
5Y return CAGR	-76.85%
5Y total return	-99.93%
6M price change	-51.84%
6M total return	-51.84%
All-time high	$2,606.40
All-time high date	2019-05-07
All-time low	$0.33
All-time low date	2026-10-13
Average true range (ATR)	$0.03
Average volume	105.4K
Beta (1Y)	3.29
Beta (2Y)	1.41
Beta (5Y)	2.37
Change from 52-week high	-83.63%
Change from 52-week low	26.97%
Change from all-time high	-99.98%
Change from all-time low	26.97%
Change from open	7.16%
Day's gap	-1.44%
Dollar volume	$114,737
High price	$0.46
Low price	$0.39
Monthly RSI	31.98
Open price	$0.39
Position in 52-week range	48.57%
Premarket change	2.6%
Premarket close	$0.42
Premarket price	$0.43
Premarket volume	5.4K
Previous close	$0.40
Price vs 150-day SMA	-31.54%
Price vs 20-day SMA	11.53%
Price vs 200-day SMA	-36.51%
Price vs 50-day SMA	-3.7%
Relative volume	2.6
RSI	56.16
Sharpe ratio	0.09
Sharpe ratio (3Y)	-0.1
Sharpe ratio (5Y)	-0.57
Sortino ratio	0.24
Sortino ratio (3Y)	-0.14
Sortino ratio (5Y)	-0.92
Volume	273.8K
Weekly RSI	39.61
YTD price change	-68.96%
YTD total return	-68.96%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10.9M
Float percentage	97.34%
Shares change (QoQ)	1.66%
Shares change (YoY)	382.43%
Shares held by insiders	2.66%
Shares held by institutions	15.2%
Shares outstanding	11.2M
Short % of float	5.01%
Short % of shares	4.87%
Short ratio	0.7 days

Deeper analysis on YCBD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this YCBD report

Is a complete YCBD research report available?

No complete published report is available for cbdMD, Inc. (YCBD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

cbdMD, Inc. (YCBD)

Price

Financial snapshot

Fair-value bridge

Latest news · YCBD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All YCBD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on YCBD

Frequently asked questions